rs199894905
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_014252.4(SLC25A15):c.337G>A(p.Gly113Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000297 in 1,614,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G113C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_014252.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC25A15 | NM_014252.4 | c.337G>A | p.Gly113Ser | missense_variant | Exon 4 of 7 | ENST00000338625.9 | NP_055067.1 | |
| TPTE2P5 | NR_038258.1 | n.623-4416C>T | intron_variant | Intron 7 of 7 | ||||
| TPTE2P5 | NR_038259.1 | n.452-4416C>T | intron_variant | Intron 5 of 5 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC25A15 | ENST00000338625.9 | c.337G>A | p.Gly113Ser | missense_variant | Exon 4 of 7 | 1 | NM_014252.4 | ENSP00000342267.4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152194Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000716 AC: 18AN: 251448 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000301 AC: 44AN: 1461820Hom.: 0 Cov.: 32 AF XY: 0.0000275 AC XY: 20AN XY: 727200 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74342 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome Pathogenic:2
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 113 of the SLC25A15 protein (p.Gly113Ser). This variant is present in population databases (rs199894905, gnomAD 0.01%). This missense change has been observed in individual(s) with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (PMID: 30187369, 30243302). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 883225). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SLC25A15 protein function. This variant disrupts the p.Gly113 amino acid residue in SLC25A15. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16601889, 19242930, 26589310, 30243302). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Inborn genetic diseases Pathogenic:1
The c.337G>A (p.G113S) alteration is located in exon 4 (coding exon 3) of the SLC25A15 gene. This alteration results from a G to A substitution at nucleotide position 337, causing the glycine (G) at amino acid position 113 to be replaced by a serine (S). Based on data from gnomAD, the A allele has an overall frequency of <0.01% (18/251448) total alleles studied. The highest observed frequency was 0.01% (15/113756) of European (non-Finnish) alleles. The p.G113S alteration has been reported as confirmed or presumably in trans with a second alteration in SLC25A15 in patients with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (Silfverberg, 2018; Wild, 2019). Another alteration at this position (p.G113C) has also been reported (reviewed in Martinelli, 2015). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26147798, Mahmoud2019[In silico], 30187369, 30243302) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at